Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
13.05
+0.09 (0.69%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Orthofix Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Orthofix Medical stock have an average target of 23.33, with a low estimate of 22 and a high estimate of 24. The average target predicts an increase of 78.77% from the current stock price of 13.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
The average analyst rating for Orthofix Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +83.91% | Feb 26, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +68.58% | Feb 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +83.91% | Jan 22, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $22 | Strong Buy | Reiterates | $20 → $22 | +68.58% | Nov 8, 2024 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $18 → $24 | Hold → Strong Buy | Upgrades | $18 → $24 | +83.91% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
838.42M
from 799.49M
Increased by 4.87%
Revenue Next Year
892.12M
from 838.42M
Increased by 6.40%
EPS This Year
0.18
from -3.30
EPS Next Year
0.59
from 0.18
Increased by 231.43%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 865.5M | 941.2M | 1.0B |
| Avg | 838.4M | 892.1M | 965.8M |
| Low | 803.4M | 843.9M | 916.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.3% | 12.3% | 12.9% |
| Avg | 4.9% | 6.4% | 8.3% |
| Low | 0.5% | 0.7% | 2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.65 | 0.80 | 0.85 |
| Avg | 0.18 | 0.59 | 0.83 |
| Low | -0.26 | 0.39 | 0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 347.1% | 43.8% |
| Avg | - | 231.4% | 39.7% |
| Low | - | 119.6% | 34.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.